[go: up one dir, main page]

IS1771B - Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif - Google Patents

Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif

Info

Publication number
IS1771B
IS1771B IS4251A IS4251A IS1771B IS 1771 B IS1771 B IS 1771B IS 4251 A IS4251 A IS 4251A IS 4251 A IS4251 A IS 4251A IS 1771 B IS1771 B IS 1771B
Authority
IS
Iceland
Prior art keywords
analgesic
carboxamide
local anesthetic
anesthetic effect
new piperidine
Prior art date
Application number
IS4251A
Other languages
English (en)
Other versions
IS4251A (is
Inventor
Ask Anna-Lena
Lars-Inge Olsson Olov
Verner Sandberg Rune
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4251A publication Critical patent/IS4251A/is
Publication of IS1771B publication Critical patent/IS1771B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS4251A 1994-02-11 1995-01-13 Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif IS1771B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9400447A SE9400447D0 (sv) 1994-02-11 1994-02-11 New compounds

Publications (2)

Publication Number Publication Date
IS4251A IS4251A (is) 1995-08-12
IS1771B true IS1771B (is) 2001-05-28

Family

ID=20392881

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4251A IS1771B (is) 1994-02-11 1995-01-13 Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif

Country Status (31)

Country Link
US (2) US5756520A (is)
EP (1) EP0743940B1 (is)
JP (1) JPH09508904A (is)
CN (1) CN1067989C (is)
AT (1) ATE192435T1 (is)
AU (1) AU686760B2 (is)
BR (1) BR9506748A (is)
CA (1) CA2181068A1 (is)
CZ (1) CZ286753B6 (is)
DE (1) DE69516671T2 (is)
DK (1) DK0743940T3 (is)
EE (1) EE03252B1 (is)
ES (1) ES2148493T3 (is)
FI (1) FI963128A0 (is)
GR (1) GR3033999T3 (is)
HR (1) HRP950414B1 (is)
HU (1) HU216734B (is)
IL (1) IL112374A (is)
IS (1) IS1771B (is)
MX (1) MX9603092A (is)
MY (1) MY130166A (is)
NO (1) NO306718B1 (is)
NZ (1) NZ281355A (is)
PL (1) PL180212B1 (is)
PT (1) PT743940E (is)
RU (1) RU2145599C1 (is)
SE (1) SE9400447D0 (is)
SK (1) SK281931B6 (is)
TW (1) TW348176B (is)
WO (1) WO1995021821A1 (is)
ZA (1) ZA95709B (is)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523526D0 (en) * 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
DE19912889A1 (de) * 1999-03-23 2000-09-28 Daimler Chrysler Ag Verfahren zur Herstellung eines Ventilsitzes
CN1744899A (zh) * 2002-12-13 2006-03-08 史密丝克莱恩比彻姆公司 作为ccr5拮抗剂的哌啶衍生物
US6916833B2 (en) * 2003-03-13 2005-07-12 Hoffmann-La Roche Inc. Substituted piperidines
FR2861074B1 (fr) * 2003-10-17 2006-04-07 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
EP2280766A1 (en) 2007-12-11 2011-02-09 CytoPathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
WO2020152212A1 (en) 2019-01-22 2020-07-30 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951080A (en) * 1957-08-05 1960-08-30 Lilly Co Eli Novel phenyl-substituted piperidines
NL130088C (is) * 1960-03-14
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
US5661162A (en) * 1992-12-14 1997-08-26 Merck Sharp & Dohme Limited 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists

Also Published As

Publication number Publication date
IL112374A (en) 1999-12-31
US5968953A (en) 1999-10-19
DK0743940T3 (da) 2000-08-14
MX9603092A (es) 1997-03-29
PT743940E (pt) 2000-08-31
CZ203296A3 (en) 1996-12-11
HUT75641A (en) 1997-05-28
MY130166A (en) 2007-06-29
SK281931B6 (sk) 2001-09-11
HRP950414A2 (en) 1997-10-31
GR3033999T3 (en) 2000-11-30
HU9602206D0 (en) 1996-10-28
ZA95709B (en) 1995-08-11
FI963128A7 (fi) 1996-08-09
EP0743940A1 (en) 1996-11-27
PL315777A1 (en) 1996-12-09
IL112374A0 (en) 1995-03-30
BR9506748A (pt) 1997-09-16
US5756520A (en) 1998-05-26
CA2181068A1 (en) 1995-08-17
CZ286753B6 (en) 2000-06-14
DE69516671T2 (de) 2001-02-01
EE03252B1 (et) 2000-02-15
SE9400447D0 (sv) 1994-02-11
NO306718B1 (no) 1999-12-13
EP0743940B1 (en) 2000-05-03
CN1067989C (zh) 2001-07-04
NZ281355A (en) 1998-02-26
HU216734B (hu) 1999-08-30
HRP950414B1 (en) 2001-02-28
IS4251A (is) 1995-08-12
FI963128L (fi) 1996-08-09
DE69516671D1 (de) 2000-06-08
NO963292L (no) 1996-08-07
RU2145599C1 (ru) 2000-02-20
AU1826995A (en) 1995-08-29
JPH09508904A (ja) 1997-09-09
ES2148493T3 (es) 2000-10-16
AU686760B2 (en) 1998-02-12
NO963292D0 (no) 1996-08-07
FI963128A0 (fi) 1996-08-09
WO1995021821A1 (en) 1995-08-17
PL180212B1 (pl) 2001-01-31
CN1140448A (zh) 1997-01-15
SK92896A3 (en) 1997-07-09
TW348176B (en) 1998-12-21
ATE192435T1 (de) 2000-05-15

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
MY119403A (en) Novel compounds with analgesic effect.
IS1771B (is) Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif
SE9401728D0 (sv) New compounds II
PL318172A1 (en) Novel analgesic pharmaceutic preparation
ATE204160T1 (de) Formulierung zur inhalativen applikation
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE271852T1 (de) Verbesserte inhalationspräparate
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
YU52495A (sh) Nova jedinjenja sa analgetskim i lokalno anestetičkim dejstvom
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
GR900100108A (el) Νεες ενωσεις τοπικης αναισθησιας και μεθοδος για την παρασκευη τους.
MX9804797A (es) Nuevos compuestos con efecto analgesico.